Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 12 | $1,270,624 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SERMON CHARLES | General Counsel | 26 Jun 2024 | Sale | 32,187 | 3.3932 | 109,217 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SERMON CHARLES | General Counsel | 25 Jun 2024 | Sale | 14,202 | 3.6939 | 52,461 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | LEWICKI JOHN A. | Chief Scientific Officer | 26 Jun 2024 | Sale | 16,808 | 3.3932 | 57,033 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | LEWICKI JOHN A. | Chief Scientific Officer | 25 Jun 2024 | Sale | 7,416 | 3.6939 | 27,394 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | FOX CHRISTINE ANN | Chief Financial Officer | 26 Jun 2024 | Sale | 29,439 | 3.3932 | 99,892 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | FOX CHRISTINE ANN | Chief Financial Officer | 25 Jun 2024 | Sale | 12,990 | 3.6939 | 47,984 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SCOTS-KNIGHT DENISE | Chief Executive Officer | 26 Jun 2024 | Sale | 92,273 | 3.3932 | 313,101 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SCOTS-KNIGHT DENISE | Chief Executive Officer | 25 Jun 2024 | Sale | 40,712 | 3.6939 | 150,386 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 26 Jun 2024 | Sale | 22,968 | 3.3932 | 77,935 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 25 Jun 2024 | Sale | 10,134 | 3.6939 | 37,434 | D |
23 May 2024 21:54 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 22 May 2024 | Sale | 50,082 | 2.94 | 147,241 | D |
23 May 2024 21:54 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 22 May 2024 | Sale | 50,350 | 2.99 | 150,546 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)